© Reuters Pfizer earnings beat by $0.07, revenue fell short of estimates   PFE -0.55% Add to/Remove from a Portfolio Add to Watchlist Add Position

Position added successfully to:

Please name your holdings portfolio Type: BUY SELL Date:   Amount: Price Point Value: Leverage: 1:1 1:10 1:25 1:50 1:100 1:200 1:400 1:500 1:1000 Commission:   Create New Watchlist Create Create a new holdings portfolio Add Create + Add another position Close

Investing.com – Pfizer (NYSE: PFE) reported fourth quarter EPS of $1.14, $0.07 better than the analyst estimate of $1.07. Revenue for the quarter came in at $24.3B versus the consensus estimate of $24.61B.

Pfizer’s stock price closed at $43.55. It is down -6.48% in the last 3 months and down -17.94% in the last 12 months.

Pfizer saw 0 positive EPS revisions and 14 negative EPS revisions in the last 90 days. See Pfizer’s stock price’s past reactions to earnings here.

According to InvestingPro, Pfizer’s Financial Health score is “great performance”.

Check out Pfizer’s recent earnings performance, and Pfizer’s financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar

Pfizer earnings beat by $0.07, revenue fell short of estimates